02/03/2015 - 2:06pm

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets. 

 

02/03/2015 - 11:54am

New York Attorney General Eric Schneiderman on Monday called on four major retailers to stop selling store-brand herbal supplement products in New York that could not be verified to contain the labeled substance by using what the industry describes as a questionable testing method — DNA barcoding.

02/02/2015 - 4:48pm

A proposal in the Budget of the U.S. government, fiscal year 2016 calls for an increase in retail pharmacy prescription drug co-pays.

02/02/2015 - 9:43am

The Food and Drug Administration announced that it has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults, making it the first FDA-approved medicine to treat this condition.

 

01/30/2015 - 1:13pm

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.

 

01/30/2015 - 11:51am

The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology released a draft roadmap toward the safe and secure exchange and use of electronic health information.

 

01/29/2015 - 4:52pm

On the heels of Wednesday’s news that the U.S. House of Representatives introduced bipartisan legislation that would formally designate pharmacists as healthcare providers under Medicare Part B, the U.S. Senate has followed suit with a companion bill.

01/29/2015 - 3:09pm

If its goal of expanding health coverage to more Americans is fully realized, the Affordable Care Act could end up pulling as many as 30 million more people into the ranks of the newly insured. That means rising prescription counts and more patients at pharmacy counters and in drug store aisles, but it also poses challenges in managing and educating patients about their benefits.

 

01/28/2015 - 4:34pm

"During one of the sessions at the 2008 NACDS Regional Chain Conference, we projected onto the video screen some images of advertisements that NACDS was beginning to use in the Washington, D.C. area. Looking back, one of the things that I remember most was the boldness and strategic focus of the tagline: 'Pharmacies. The face of neighborhood healthcare.' With the 2015 edition of this meeting just days away, it is striking how far we have come!" writes NACDS president and CEO Steve Anderson in his latest blog post.